Clinical trial
Interventional Clinical Trial to Assess Efficacy and Safety of the Extemporaneous Combination of Zofenopril Calcium and Amlodipine in Grade 1-2 Hypertensive Patients Versus Each Monotherapy - (MASOLINO Study)
NCT05279807 is registered in ClinicalTrials.gov with Menarini International Operations Luxembourg SA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Interventional Clinical Trial to Assess Efficacy and Safety of the Extemporaneous Combination of Zofenopril Calcium and Amlodipine in Grade 1-2 Hypertensive Patients Versus Each Monotherapy - (MASOLINO Study)
- Lead sponsor
- Menarini International Operations Luxembourg SA
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 15, 2021
- Completion date
- April 28, 2022
- Enrollment
- 277 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.